Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, randomized trial

BACKGROUND: Single-agent chemotherapy using methotrexate or actinomycin D is the first-line treatment for patients with low-risk gestational trophoblastic neoplasia. Various methotrexate-based and actinomycin D-based single-agent regimens can be used. However, there is insufficient evidence to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Fang, Mao, Ming-yi, Xiang, Yang, Lu, Xin, Guan, Chong-li, Jiao, Lan-zhou, Wan, Xi-Run, Feng, Feng-Zhi, Ren, Tong, Yang, Jun-Jun, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464396/
https://www.ncbi.nlm.nih.gov/pubmed/37612621
http://dx.doi.org/10.1186/s12885-023-11225-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464396/
https://www.ncbi.nlm.nih.gov/pubmed/37612621
http://dx.doi.org/10.1186/s12885-023-11225-2

Ejemplares similares